IL1B and hepatocellular carcinoma: Edu assays and transwell experiments were performed, and we found IL1B treatment not only stimulated the abilities of proliferation and invasion in normal cell lines but also rescued the defects of proliferation and invasion in CD44s deficient cells, indicating decreased IL1B was responsible for HCC inhibition caused by CD44s deficiency (Fig. 5b–e).